AbbVie
ABBV
#35
Rank
A$557.25 B
Marketcap
A$315.41
Share price
-0.56%
Change (1 day)
11.61%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$203.98 Billion

According to AbbVie's latest financial reports the company's total liabilities are A$203.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$204.81 B-3.34%
2024-12-31A$211.89 B16.13%
2023-12-31A$182.46 B2.18%
2022-12-31A$178.57 B-1.25%
2021-12-31A$180.82 B1.14%
2020-12-31A$178.77 B28.66%
2019-12-31A$138.95 B44.38%
2018-12-31A$96.23 B14.38%
2017-12-31A$84.14 B-1.32%
2016-12-31A$85.26 B26.5%
2015-12-31A$67.40 B114.06%
2014-12-31A$31.48 B13.69%
2013-12-31A$27.69 B21.73%
2012-12-31A$22.75 B207.42%
2011-12-31A$7.40 B38.41%
2010-12-31A$5.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$167.11 B-18.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$121.72 B-40.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$118.78 B-41.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$15.44 B-92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$46.82 B-77.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$94.62 B-53.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$94.99 B-53.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$85.80 B-57.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$2.13 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA